FAST-Forward Boost Trial Aims to Shorten Breast Cancer Radiotherapy
Audio narration · Coming soon
The FAST-Forward Boost trial, led by the Institute of Cancer Research in the UK, aims to safely reduce the duration of radiotherapy for breast cancer patients. This trial seeks to improve treatment efficiency while maintaining safety standards.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews